Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency, Chronic | 4 | 2023 | 486 | 2.290 |
Why?
|
| Spices | 2 | 2022 | 5 | 1.490 |
Why?
|
| Vascular Stiffness | 3 | 2023 | 407 | 0.890 |
Why?
|
| Postprandial Period | 2 | 2022 | 87 | 0.860 |
Why?
|
| Cardiovascular System | 1 | 2023 | 125 | 0.780 |
Why?
|
| Cardiovascular Diseases | 2 | 2023 | 1727 | 0.770 |
Why?
|
| Dietary Carbohydrates | 1 | 2020 | 138 | 0.660 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 493 | 0.650 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2022 | 447 | 0.610 |
Why?
|
| Dietary Fats | 1 | 2020 | 287 | 0.610 |
Why?
|
| Cytokines | 2 | 2023 | 1841 | 0.590 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 927 | 0.480 |
Why?
|
| Diet | 1 | 2022 | 1080 | 0.470 |
Why?
|
| Monocytes | 2 | 2023 | 504 | 0.340 |
Why?
|
| Cross-Over Studies | 2 | 2022 | 440 | 0.330 |
Why?
|
| Anti-Obesity Agents | 3 | 2015 | 45 | 0.260 |
Why?
|
| Hypercapnia | 2 | 2023 | 51 | 0.260 |
Why?
|
| Phytotherapy | 2 | 2014 | 66 | 0.220 |
Why?
|
| Blood Pressure | 3 | 2023 | 1538 | 0.200 |
Why?
|
| Nutrition Surveys | 1 | 2023 | 224 | 0.200 |
Why?
|
| Plant Extracts | 2 | 2014 | 154 | 0.200 |
Why?
|
| Pulse Wave Analysis | 1 | 2023 | 207 | 0.200 |
Why?
|
| Postmenopause | 1 | 2023 | 303 | 0.190 |
Why?
|
| Aged | 4 | 2023 | 19074 | 0.190 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2022 | 124 | 0.190 |
Why?
|
| Leukocyte Count | 1 | 2022 | 293 | 0.190 |
Why?
|
| Cerebrovascular Circulation | 1 | 2023 | 221 | 0.180 |
Why?
|
| Meals | 1 | 2022 | 104 | 0.180 |
Why?
|
| Dementia | 1 | 2023 | 187 | 0.180 |
Why?
|
| Fasting | 1 | 2022 | 241 | 0.180 |
Why?
|
| Reactive Oxygen Species | 1 | 2023 | 531 | 0.170 |
Why?
|
| Lymphocytes | 1 | 2022 | 330 | 0.170 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2023 | 209 | 0.170 |
Why?
|
| Cell Culture Techniques | 1 | 2022 | 343 | 0.160 |
Why?
|
| Testosterone | 1 | 2022 | 343 | 0.160 |
Why?
|
| Sex Characteristics | 1 | 2023 | 641 | 0.160 |
Why?
|
| Humans | 10 | 2023 | 114689 | 0.150 |
Why?
|
| Metabolic Syndrome | 1 | 2022 | 321 | 0.150 |
Why?
|
| Male | 6 | 2023 | 55599 | 0.150 |
Why?
|
| Endothelial Cells | 1 | 2023 | 687 | 0.150 |
Why?
|
| Diet, High-Fat | 2 | 2015 | 225 | 0.140 |
Why?
|
| Overweight | 1 | 2020 | 472 | 0.130 |
Why?
|
| Rutin | 1 | 2015 | 2 | 0.130 |
Why?
|
| Organelle Biogenesis | 1 | 2015 | 15 | 0.130 |
Why?
|
| Peripheral Arterial Disease | 1 | 2021 | 380 | 0.130 |
Why?
|
| Panax | 1 | 2014 | 2 | 0.120 |
Why?
|
| Acute Kidney Injury | 1 | 2021 | 638 | 0.120 |
Why?
|
| Kidney | 1 | 2021 | 1188 | 0.120 |
Why?
|
| Mitochondria, Muscle | 1 | 2015 | 93 | 0.120 |
Why?
|
| Adipogenesis | 1 | 2014 | 42 | 0.120 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2015 | 172 | 0.120 |
Why?
|
| Middle Aged | 3 | 2023 | 26737 | 0.110 |
Why?
|
| Obesity | 3 | 2015 | 2508 | 0.110 |
Why?
|
| Female | 4 | 2023 | 59511 | 0.110 |
Why?
|
| Hypertension | 1 | 2021 | 1056 | 0.110 |
Why?
|
| Nanocapsules | 1 | 2013 | 8 | 0.110 |
Why?
|
| Risk Factors | 2 | 2022 | 8632 | 0.100 |
Why?
|
| Prospective Studies | 1 | 2022 | 6220 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 1473 | 0.070 |
Why?
|
| Dinoprost | 1 | 2023 | 31 | 0.060 |
Why?
|
| C-Reactive Protein | 1 | 2023 | 362 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2023 | 387 | 0.050 |
Why?
|
| Adult | 1 | 2022 | 30550 | 0.040 |
Why?
|
| Antioxidants | 1 | 2023 | 530 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2023 | 460 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2015 | 2218 | 0.040 |
Why?
|
| Time Factors | 2 | 2021 | 6116 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2021 | 604 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2023 | 1076 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 1214 | 0.030 |
Why?
|
| Cognition | 1 | 2023 | 989 | 0.030 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2015 | 3 | 0.030 |
Why?
|
| Mitochondrial Size | 1 | 2015 | 3 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2015 | 42 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2015 | 29 | 0.030 |
Why?
|
| Incidence | 1 | 2021 | 2313 | 0.030 |
Why?
|
| Hydrostatic Pressure | 1 | 2014 | 18 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2014 | 31 | 0.030 |
Why?
|
| Adipocytes, White | 1 | 2014 | 17 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2015 | 182 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 3329 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 785 | 0.030 |
Why?
|
| Biomarkers | 1 | 2023 | 3408 | 0.030 |
Why?
|
| Inflammation | 1 | 2023 | 2480 | 0.030 |
Why?
|
| Emulsions | 1 | 2013 | 42 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2968 | 0.030 |
Why?
|
| Adiposity | 1 | 2015 | 458 | 0.020 |
Why?
|
| Weight Loss | 1 | 2015 | 642 | 0.020 |
Why?
|
| Animals | 3 | 2015 | 31706 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2015 | 1528 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 3535 | 0.020 |
Why?
|
| Rats | 1 | 2013 | 4958 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2015 | 4513 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 14869 | 0.010 |
Why?
|